Abstract
Immune checkpoint inhibitors are effective for metastatic melanoma, but little is known about how is the efficacy and toxicity of this therapy in Turkish patients with metastatic melanoma. Here we present real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
